Assessing the validity of a Parkinson's care evaluation: the PRIME-NL study.
Liza M Y GelissenRobin van den BerghAmir H TalebiAngelika D GeerlingsBart R MaasMyrthe M BurglerYvet KroezeAgnes SminkBastiaan R BloemMarten MunnekeYoav Ben-ShlomoSirwan K L DarweeshPublished in: European journal of epidemiology (2024)
The generalizability of the PRIME-NL study seems to be good, yet we found evidence of some selection bias. This selection bias necessitates the use of advanced statistical methods for the final evaluation of PRIME-NL, such as inverse probability weighting or propensity score matching. The PRIME-NL study provides a unique window into the validity of a large-scale care evaluation for people with a chronic disease, in this case parkinsonism.